This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.
Registration ID: 986571
Submitted by lobbyist on: June 4, 2019 09:24:31 AM
Accepted by Registrar on: June 4, 2019 10:01:06 AM
Designated Filer Information
| Miziolek, Gregory |
| 2100 Derry Road West | |
|
Mississauga, ON, L5N 0B3
|
905-288-6141 |
| Canada |
Organization Information
| Becton Dickinson Canada Inc |
| BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and healthcare worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures and support the management of diabetes. |
| 2100 Derry Road West | |
|
Mississauga, BC, L5N 0B3
|
905-288-6061 |
| Canada |
Relevant Affiliates
Type:
| Business Name | Mailing Address | Contact Information |
|---|---|---|
| Becton, Dickinson and Company |
1 Becton Drive
Franklin Lakes, NJ 07417 United States of America |
Phone: |
Government or Government Agency Funding
Other Controlling or Directing Interests
Active Registration Period
| June 4, 2019 | |
| December 4, 2019 |
Organization's In-House Lobbyists
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Development, establishment, amendment or termination of any program, policy or decision
Introduction, modification or repeal of legislation, a bill or regulation
British Columbia budget with respect to science and technology in the healthcare sector, specifically with respect to medical technology and devices. British Columbia budget with respect to public sector investments in long-term care and residential care. British Columbia healthcare strategy with respect to patient safety, managing high-risk drugs, medication errors, healthcare worker safety, infection and disease prevention, antimicrobial resistance, and laboratory diagnostic testing. British Columbia science & technology strategy with respect to medical technology, specifically focusing on accelerating innovation to improve health and economic outcomes. British Columbia guidelines with respect to procurement of medical technologies and adoption of innovation in the healthcare industry. British Columbia science & technology strategy focusing on promoting collaboration with respect to clinical and scientific research in the healthcare industry. British Columbia healthcare strategy with respect to diabetes, cancer testing and long-term care. British Columbia policies related to lab testing and code approvals for reimbursement.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | BC Patient Safety and Quality Council | June 4, 2019 | |
| Public Agency | Health | June 4, 2019 | |
| Public Agency | Providence Health Care Society | June 4, 2019 | |
| Public Agency | Provincial Health Services Authority | June 4, 2019 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Development, establishment, amendment or termination of any program, policy or decision
Introduction, modification or repeal of legislation, a bill or regulation
British Columbia budget with respect to science and technology in the healthcare sector, specifically with respect to medical technology and devices. British Columbia budget with respect to public sector investments in long-term care and residential care. British Columbia healthcare strategy with respect to patient safety, managing high-risk drugs, medication errors, healthcare worker safety, infection and disease prevention, antimicrobial resistance, and laboratory diagnostic testing. British Columbia science & technology strategy with respect to medical technology, specifically focusing on accelerating innovation to improve health and economic outcomes. British Columbia guidelines with respect to procurement of medical technologies and adoption of innovation in the healthcare industry. British Columbia science & technology strategy focusing on promoting collaboration with respect to clinical and scientific research in the healthcare industry. British Columbia healthcare strategy with respect to diabetes, cancer testing and long-term care. British Columbia policies related to lab testing and code approvals for reimbursement.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | BC Patient Safety and Quality Council | June 4, 2019 | |
| Public Agency | Health | June 4, 2019 | |
| Public Agency | Providence Health Care Society | June 4, 2019 | |
| Public Agency | Provincial Health Services Authority | June 4, 2019 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Development, establishment, amendment or termination of any program, policy or decision
Introduction, modification or repeal of legislation, a bill or regulation
British Columbia budget with respect to science and technology in the healthcare sector, specifically with respect to medical technology and devices. British Columbia budget with respect to public sector investments in long-term care and residential care. British Columbia healthcare strategy with respect to patient safety, managing high-risk drugs, medication errors, healthcare worker safety, infection and disease prevention, antimicrobial resistance, and laboratory diagnostic testing. British Columbia science & technology strategy with respect to medical technology, specifically focusing on accelerating innovation to improve health and economic outcomes. British Columbia guidelines with respect to procurement of medical technologies and adoption of innovation in the healthcare industry. British Columbia science & technology strategy focusing on promoting collaboration with respect to clinical and scientific research in the healthcare industry. British Columbia healthcare strategy with respect to diabetes, cancer testing and long-term care. British Columbia policies related to lab testing and code approvals for reimbursement.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | BC Patient Safety and Quality Council | June 4, 2019 | |
| Public Agency | Health | June 4, 2019 | |
| Public Agency | Providence Health Care Society | June 4, 2019 | |
| Public Agency | Provincial Health Services Authority | June 4, 2019 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Development, establishment, amendment or termination of any program, policy or decision
Introduction, modification or repeal of legislation, a bill or regulation
British Columbia budget with respect to science and technology in the healthcare sector, specifically with respect to medical technology and devices. British Columbia budget with respect to public sector investments in long-term care and residential care. British Columbia healthcare strategy with respect to patient safety, managing high-risk drugs, medication errors, healthcare worker safety, infection and disease prevention, antimicrobial resistance, and laboratory diagnostic testing. British Columbia science & technology strategy with respect to medical technology, specifically focusing on accelerating innovation to improve health and economic outcomes. British Columbia guidelines with respect to procurement of medical technologies and adoption of innovation in the healthcare industry. British Columbia science & technology strategy focusing on promoting collaboration with respect to clinical and scientific research in the healthcare industry. British Columbia healthcare strategy with respect to diabetes, cancer testing and long-term care. British Columbia policies related to lab testing and code approvals for reimbursement.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | BC Patient Safety and Quality Council | June 4, 2019 | |
| Public Agency | Health | June 4, 2019 | |
| Public Agency | Providence Health Care Society | June 4, 2019 | |
| Public Agency | Provincial Health Services Authority | June 4, 2019 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Development, establishment, amendment or termination of any program, policy or decision
Introduction, modification or repeal of legislation, a bill or regulation
British Columbia budget with respect to science and technology in the healthcare sector, specifically with respect to medical technology and devices. British Columbia budget with respect to public sector investments in long-term care and residential care. British Columbia healthcare strategy with respect to patient safety, managing high-risk drugs, medication errors, healthcare worker safety, infection and disease prevention, antimicrobial resistance, and laboratory diagnostic testing. British Columbia science & technology strategy with respect to medical technology, specifically focusing on accelerating innovation to improve health and economic outcomes. British Columbia guidelines with respect to procurement of medical technologies and adoption of innovation in the healthcare industry. British Columbia science & technology strategy focusing on promoting collaboration with respect to clinical and scientific research in the healthcare industry. British Columbia healthcare strategy with respect to diabetes, cancer testing and long-term care. British Columbia policies related to lab testing and code approvals for reimbursement.
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | BC Patient Safety and Quality Council | June 4, 2019 | |
| Public Agency | Health | June 4, 2019 | |
| Public Agency | Providence Health Care Society | June 4, 2019 | |
| Public Agency | Provincial Health Services Authority | June 4, 2019 |